P
Portage Biotech D
D
PRTG
3.97000
USD
-0.30
(-7.03%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
0
Market Cap
4,163,597
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Portage Biotech Inc
Sector: Healthcare
Industry: Biotechnology
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immuneresistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.